CellaVision AB

C26

Company Profile

  • Business description

    CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers or software.

  • Contact

    Mobilvagen 12
    Lund22362
    SWE

    T: +46 464601600

    https://www.cellavision.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    248

Stocks News & Analysis

stocks

New production imminent for undervalued ASX gas play

LNG project receives first commissioning gas.
stocks

Going into earnings, is Tesla stock a buy, a sell, or fairly valued?

Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
stocks

Why I dislike dividend stocks

If you need income then buying dividend stocks makes perfect sense. But if you don’t then it makes little sense because it’s likely to limit building real wealth. Here’s what you should do instead.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,293.2045.10-0.48%
CAC 408,174.2014.39-0.18%
DAX 4023,830.99441.20-1.82%
Dow JONES (US)46,190.61238.370.52%
FTSE 1009,354.5781.52-0.86%
HKSE25,247.10641.41-2.48%
NASDAQ22,679.97117.440.52%
Nikkei 22547,582.15695.59-1.44%
NZX 50 Index13,289.2199.89-0.75%
S&P 5006,664.0134.940.53%
S&P/ASX 2008,995.3034.70-0.38%
SSE Composite Index3,839.7676.47-1.95%

Market Movers